Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -84.79% is 18% above its 5-year average of -102.91%, around the middle of its 5-year range (-206.14%–0.14%).
26.76% above its 12-month average of -115.77%.
Reported quarterly profit margin; no daily interpolation. Q4 FY2026 (2026-05-31): -130.86%.
NET PROFIT MARGIN
-84.79%
NET PROFIT MARGIN AVG TTM
-115.77%
NET PROFIT MARGIN AVG 3Y
-111.82%
NET PROFIT MARGIN AVG 5Y
-102.91%
NET PROFIT MARGIN AVG 10Y
-76.36%
NET PROFIT MARGIN AVG 15Y
-51.54%
NET PROFIT MARGIN AVG 20Y
-32.55%
CURRENT VS TTM AVG
+26.76%
CURRENT VS 3Y AVG
+24.17%
CURRENT VS 5Y AVG
+17.61%
CURRENT VS 10Y AVG
-11.04%
CURRENT VS 15Y AVG
-64.53%
CURRENT VS 20Y AVG
-160.48%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 386 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Biomerica, Inc.
Market Cap
$6.34M
Net Profit Margin
-84.79%
TTM Avg
-115.77%
3Y Avg
-111.82%
5Y Avg
-102.91%
Market Cap
$6.44M
Net Profit Margin
-1084.23%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$6.10M
Net Profit Margin
-534.27%
TTM Avg
-983.65%
3Y Avg
-1060.24%
5Y Avg
-924.37%
Market Cap
$6.10M
Net Profit Margin
-44771.83%
TTM Avg
-33930.36%
3Y Avg
-151894.64%
5Y Avg
-112740.11%
Market Cap
$6.09M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-86.55%
Market Cap
$6.03M
Net Profit Margin
-9366.75%
TTM Avg
-6298.14%
3Y Avg
-3910.26%
5Y Avg
-3305.87%
Market Cap
$6.72M
Net Profit Margin
-611.47%
TTM Avg
-627.26%
3Y Avg
-917.71%
5Y Avg
-6297.45%
Market Cap
$6.74M
Net Profit Margin
-10978.48%
TTM Avg
-12422.83%
3Y Avg
-10763.38%
5Y Avg
-10131.90%
Market Cap
$6.76M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biomerica, Inc. (BMRA) | $6.34M | -84.79% | -115.77% | -111.82% | -102.91% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.44M | -1084.23% | 0.00% | 0.00% | 0.00% |
| Femasys Inc. (FEMY)vs › | $6.10M | -534.27% | -983.65% | -1060.24% | -924.37% |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $6.10M | -44771.83% | -33930.36% | -151894.64% | -112740.11% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.09M | 0.00% | 0.00% | 0.00% | -86.55% |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $6.03M | -9366.75% | -6298.14% | -3910.26% | -3305.87% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | -611.47% | -627.26% | -917.71% | -6297.45% |
| Aclarion, Inc. (ACON)vs › | $6.74M | -10978.48% | -12422.83% | -10763.38% | -10131.90% |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.76M | 0.00% | 0.00% | 0.00% | 0.00% |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | -6523.04% | -4247.49% | -2263.82% | -1493.48% |
Operating Margin
-119.5%
Net Profit Margin
-84.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-05-31 | -130.86% |
| 2026-02-28 | -132.93% |
| 2025-11-30 | -109.09% |
| 2025-08-31 | 0.14% |
| 2025-05-31 | -206.14% |
| 2025-02-28 | -103.93% |
| 2024-11-30 | -58.07% |
| 2024-08-31 | -72.83% |
| 2024-05-31 | -127.33% |
| 2024-02-29 | -188.59% |
| 2023-11-30 | -96.17% |
| 2023-08-31 | -66.08% |
| 2023-05-31 | -161.72% |
| 2023-02-28 | -148.44% |
| 2022-11-30 | -109.73% |
| 2022-08-31 | -126.53% |
| 2022-05-31 | -33.18% |
| 2022-02-28 | -1.36% |
| 2021-11-30 | -24.22% |
| 2021-08-31 | -122.25% |
| 2021-05-31 | -141.85% |
| 2021-02-28 | -58.55% |
| 2020-11-30 | -125.18% |
| 2020-08-31 | -165.45% |
| 2020-05-31 | -17.86% |
| 2020-02-29 | -73.15% |
| 2019-11-30 | -30.40% |
| 2019-08-31 | -42.39% |
| 2019-05-31 | -67.36% |
| 2019-02-28 | -53.82% |
| 2018-11-30 | -31.80% |
| 2018-08-31 | -35.49% |
| 2018-05-31 | -59.06% |
| 2018-02-28 | -23.44% |
| 2017-11-30 | -16.65% |
| 2017-08-31 | -14.33% |
| 2017-05-31 | -23.86% |
| 2017-02-28 | -20.28% |
| 2016-11-30 | -14.17% |
| 2016-08-31 | -3.93% |
| 2016-05-31 | -92.43% |
| 2016-02-29 | -9.91% |
| 2015-11-30 | -5.73% |
| 2015-08-31 | -5.62% |
| 2015-05-31 | 16.26% |
| 2015-02-28 | -9.02% |
| 2014-11-30 | -21.00% |
| 2014-08-31 | -21.20% |
| 2014-05-31 | 10.06% |
| 2014-02-28 | 1.78% |
| 2013-11-30 | -26.03% |
| 2013-08-31 | -16.54% |
| 2013-05-31 | 2.99% |
| 2013-02-28 | -2.51% |
| 2012-11-30 | 12.58% |
| 2012-08-31 | 17.14% |
| 2012-05-31 | 3.51% |
| 2012-02-29 | 11.98% |
| 2011-11-30 | 12.07% |
| 2011-08-31 | 8.37% |
| 2011-07-29 | 7.91% |
| 2011-02-28 | 5.45% |
| 2010-11-30 | 0.01% |
| 2010-08-31 | -1.03% |
| 2010-05-31 | -11.97% |
| 2010-02-28 | 9.35% |
| 2009-11-30 | -27.79% |
| 2009-08-31 | 0.69% |
| 2009-05-31 | 3.18% |
| 2009-02-28 | 20.15% |
| 2008-11-30 | -9.19% |
| 2008-08-31 | 11.79% |
| 2008-05-31 | 52.91% |
| 2008-02-29 | 9.98% |
| 2007-11-30 | 0.33% |
| 2007-08-31 | 66.07% |
| 2007-05-31 | 15.39% |
| 2007-02-28 | 9.25% |
| 2006-11-30 | 7.99% |
| 2006-08-31 | 5.60% |
| 2006-05-31 | 9.23% |
| 2006-02-28 | 2.97% |
| 2005-11-30 | 0.08% |
| 2005-08-31 | 2.73% |
| 2005-05-31 | 8.10% |
| 2005-02-28 | 3.08% |
| 2004-11-30 | -3.18% |
| 2004-08-31 | -2.30% |
| 2004-05-31 | 1.99% |
| 2004-02-29 | 2.56% |
| 2003-11-30 | -5.00% |
| 2003-08-31 | -10.07% |
| 2003-05-31 | 4.74% |
| 2003-02-28 | -1.14% |
| 2002-11-30 | -7.88% |
| 2002-08-31 | -6.48% |
